Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
The National Lipid Association Lipid Insights podcast series brings you engaging discussions on the most relevant, timely, and groundbreaking topics in lipidology. Hosted by Dr. Alan Brown and Dr. Peter Jones, this series explores the latest research, emerging treatments, and key developments in the field. Whether it’s expert analysis on hot topics, deep dives into new clinical data, or conversations about the evolving landscape of lipid management, each episode delivers insightful and thought-provoking content. With their expertise and dynamic hosting style, Dr. Brown and Dr. Jones make each discussion both informative and entertaining—ensuring listeners walk away with valuable knowledge to enhance their understanding and clinical practice. Tune in to stay at the forefront of lipidology!
| Episode | Date |
|---|---|
|
S7E14: Lp(a) After HORIZON: What the Results Mean for Cardiovascular Prevention
|
Nov 10, 2026 |
|
From Cholesterol to Dyslipidemia: Achieving Lipid Goals: From Clinical Strategy to Real-World Practice | Episode 3
|
Oct 31, 2026 |
|
S7E13: "Sterology" 101: A Deep Dive into Cholesterol and the Sterol Family with Dr. Lipid
|
Oct 21, 2026 |
|
S7E12: Lipid Insights × The Tell-Tale Heart: Lipid Management in 2026
|
Oct 09, 2026 |
|
From Cholesterol to Dyslipidemia: Beyond LDL: The Biomarkers That Matter | Episode 2
|
Sep 30, 2026 |
|
S7E11: Catching FH Early: Point-of-Care Testing in 2-Year-Olds
|
Sep 24, 2026 |
|
From Cholesterol to Dyslipidemia: Why the Dyslipidemia Guideline Had to Change | Episode 1
|
Sep 14, 2026 |
|
S7E10: Fresh from Munich: Plozasiran and the SHASTA-3 & SHASTA-4 Trial Results
|
Sep 04, 2026 |
|
Industry Innovations | Episode 7: A New Era for FCS: Diagnosis, Daily Life & the Science That's Changing Everything
|
Aug 26, 2026 |
|
S7E9: HDL Under the Microscope: Setting the Record Straight with Dr. Lipid
|
Aug 12, 2026 |
|
S7E8: Thinking Long-Term: LDL Exposure, Longevity Medicine, and the Future of Cardiovascular Prevention
|
Jul 01, 2026 |
|
S7E7: National Lipid Day Special: The Lipid Doctor’s Truths Every Clinician Should Know
|
May 10, 2026 |
|
S7E6: Identification of Rare Lipid Disorders in Children
|
Apr 16, 2026 |
|
S7E5: Tackling Childhood Obesity: Innovative Strategies for a Healthier Future
|
Apr 03, 2026 |
|
S7E4: 2026 ACC/AHA Cholesterol (Dyslipidemia) Guidelines: Clinical Meaning for Lipidologists
|
Mar 17, 2026 |
|
S7E3: LDL-C Reduction in Primary Prevention: Insights from a New Meta-Analysis
|
Mar 05, 2026 |
|
S7E2: Addressing Obesity and Weight Loss Challenges: Implications for Cardiometabolic Health
|
Feb 19, 2026 |
|
S7 E1: Changing the FH Playbook: Diagnosis and Treatment Updates from the NLA
|
Jan 29, 2026 |
|
S6E13: The Next Era of Prevention: Rethinking Cardiovascular Health from the Ground Up
|
Dec 17, 2025 |
|
S6E12: ATTAIN in Practice: Translating Data Into Lipid Decisions
|
Dec 04, 2025 |
|
S6E11: Managing Lipids and Metabolic Syndrome in Youth: Tips from the Experts
|
Nov 14, 2025 |
|
S6E10: Rewriting the Risk Equation: The Expanding Role of Lp(a) in Atherosclerotic Disease
|
Oct 29, 2025 |
|
S6 Lipid Snippet: Polygenic Risk Score for Coronary Artery Disease Predicts ASCVD in FH
|
Sep 25, 2025 |
|
S6E9:Beef and Cardiovascular Disease: What the Science Says
|
Sep 17, 2025 |
|
S6 Lipid Snippet: Universal Lipoprotein(a) Screening of Youth and Reverse Cascade Screening at a Primary Care Clinic
|
Sep 12, 2025 |
|
S6E8: The Long Game with LDL: Lower, Longer, Better
|
Sep 04, 2025 |
|
S6E7: Next-Gen Lipid-Lowering Strategies: ANGPTL4 Inhibitor Clinical Insights
|
Aug 20, 2025 |
|
S6E6: All Hands on Deck: The Power of Multidisciplinary Lipid Care
|
Aug 07, 2025 |
|
S6E5: Recognition and Management of Persistent Chylomicronemia
|
Jul 23, 2025 |
|
S6E4: Familial Chylomicronemia Syndrome An Expert Clinical Review from the National Lipid Association
|
Apr 07, 2025 |
|
S6E3: Diets and Supplements
|
Mar 25, 2025 |
|
S6E2: From Research to Reality: Advancing FCS Therapy
|
Feb 28, 2025 |
|
S6E1: The role of nutrition-related clinical trials in informing dietary recommendations for health and treatment of diseases
|
Jan 30, 2025 |
|
S5E4: Role of apolipoprotein B in the Clinical Management of Cardiovascular Risk in Adults
|
Oct 09, 2024 |
|
S5E5: Managing Hypercholesterolemia in Adults Aged 75 Years & Older w/o a History of ASCVD: A Scientific Statement from the NLA & AGS
|
Oct 09, 2024 |
|
S5E3: What’s next for Lipoprotein(a)? Insights from an Expert Discussion Group
|
Oct 04, 2024 |
|
S5E2: Palisade Phase 3 Data
|
Sep 03, 2024 |
|
S5E1: A Focused Update to the 2019 NLA Scientific Statement On The Use of Lp(a) in Clinical Practice
|
May 03, 2024 |
|
S4E2: Nutrition Interventions for Adults with Dyslipidemia
|
Jul 31, 2023 |
|
S4E1: The importance of low-density lipoprotein cholesterol measurement and control as performance measures
|
Mar 28, 2023 |
|
S3E2: Statin Underuse Persistence
|
Dec 05, 2022 |
|
S3E1: Tables Turned
|
Feb 01, 2022 |
|
S2E6: Women's Cardiovascular Health
|
Oct 18, 2021 |
|
S2E5: Practical Approaches to Cardiovascular Risk Reduction in the Era of PCSK9 Inhibitors
|
Sep 09, 2021 |
|
S2E4: Genetic Variations in Patients with Very High LDL Cholesterol Including Familial Hypercholesterolemia
|
May 04, 2021 |
|
S2E3: Evinacumab: A new therapeutic option to treat dyslipidemia
|
Apr 05, 2021 |
|
S2E2: CAC Scoring: A Discussion on the Recent NLA Scientific Statement
|
Mar 02, 2021 |
|
S2E1: Omega 3 Outcome Trials in Perspective Part 2
|
Feb 08, 2021 |
|
S2E1: Omega 3 Outcome Trials in Perspective Part 1
|
Feb 05, 2021 |
|
S1E4: Special Edition: New Lipid Therapies
|
Oct 02, 2020 |
|
S1E3: Genetic Testing in Dyslipidemia
|
Aug 14, 2020 |
|
S1E2: General Gaps in FH Care
|
Jun 08, 2020 |
|
S1E1: Clinical Pearls on Provider Methods for Obtaining Prior Authorizations for PCSK9i
|
Apr 01, 2020 |